Metraipolis › archive › dc_dbfbb8df64a6

PML as a neuroprotective guardian: Leveraging nuclear protein quality control to mitigate neurotoxicity of an ALS-associated NEK1 variant — Europe PMC PMID:42317073

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42317073
DOI
10.1111/febs.70630
License (as archived)
solo-consultazione
Archived
2026-10-19T07:55:22.403Z
SHA-256 of the archived text
7cafafacadfe84da106f8aa378b82072d6da66c836e071b6e7c681ce18fc6c8d
Stable URL of this page
https://metraipolis.com/documento/dc_dbfbb8df64a6

How to cite

PML as a neuroprotective guardian: Leveraging nuclear protein quality control to mitigate neurotoxicity of an ALS-associated NEK1 variant — Europe PMC PMID:42317073 — Europe PMC (en), https://europepmc.org/article/MED/42317073 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbfbb8df64a6 (Metraipolis archive dc_dbfbb8df64a6, sha256 7cafafacadfe84da106f8aa378b82072d6da66c836e071b6e7c681ce18fc6c8d)
BibTeX
@misc{dcdbfbb8df64a6,
  title = {PML as a neuroprotective guardian: Leveraging nuclear protein quality control to mitigate neurotoxicity of an ALS-associated NEK1 variant — Europe PMC PMID:42317073},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42317073},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbfbb8df64a6; sha256 7cafafacadfe84da106f8aa378b82072d6da66c836e071b6e7c681ce18fc6c8d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42317073. Agents can read the archived copy with the MCP tool read_document.